Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on L 1. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115747838A details a green electrochemical method for C3 amination of quinoxalinones, offering cost-effective and scalable pharma intermediate manufacturing solutions.
Patent CN106866389A reveals copper-catalyzed asymmetric synthesis. Offers high enantioselectivity up to 95% ee for pharmaceutical intermediates.
Patent CN107011218A details copper catalyzed asymmetric amination enabling efficient synthesis of chiral amines with improved supply chain reliability and cost effectiveness for global buyers
Patent CN117362140B reveals high-yield photocatalytic route. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel cobalt-catalyzed carbonylation method offers cost-effective scalable production for pharmaceutical intermediates with high purity and operational simplicity for global supply chains.
Novel silver oxide promoted method ensures high purity and scalable production for global pharmaceutical supply chains efficiently reducing operational complexity and enhancing sourcing stability significantly.
Patent CN105859620B reveals novel phenanthridine synthesis enabling cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN116813544B reveals catalyst-free heating method for quinoline. Reduces cost and improves supply chain reliability for pharmaceutical intermediates globally.
Patent CN108503574A enables efficient Pd-Cu co-catalyzed synthesis. Delivers high-purity pharmaceutical intermediates with reduced cost and scalable supply chain reliability.
Novel Rh-catalyzed one-pot synthesis of indolo[2,1-a]isoquinolines using sulfur ylides. Efficient route for pharmaceutical intermediates with mild conditions.
Patent CN114195818B enables metal-free synthesis of high-purity 4-arylthiocoumarin intermediates, offering substantial cost reduction and scalable supply chain reliability for global pharmaceutical manufacturers.
Patent CN111423381B details a mild palladium-catalyzed carbonylation route for 2-trifluoromethyl imidazoles, offering reliable pharmaceutical intermediate supply with enhanced cost efficiency.
Patent CN113307778A reveals a novel Mo/Cu co-catalyzed route for 3-trifluoromethyl-1,2,4-triazoles, offering mild conditions and high efficiency for API manufacturing.
Novel iodine-promoted synthesis of 5-trifluoromethyl-1,2,4-triazoles. Cost-effective, scalable route for API intermediates without heavy metals.
Patent CN111423381B reveals a mild Pd-catalyzed route to 2-trifluoromethyl imidazoles, offering significant cost reduction in API manufacturing and reliable supply chain solutions.
Novel synthesis route for 7-(trifluoromethyl) isoquinoline-5-amine. High purity pharmaceutical intermediate with scalable process and cost advantages for global supply chains.
Novel palladium-catalyzed route for 3-arylquinolinone derivatives offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN110818631A reveals a green thiourea route for Apalutamide. Discover cost reduction in pharmaceutical manufacturing and high-purity intermediate supply strategies.
Novel silver oxide promoted method ensures high purity pharmaceutical intermediates. Significant cost reduction and scalable supply chain reliability for global buyers.
Patent CN113683595B reveals sulfur-promoted synthesis for high-purity triazole intermediates. Enables cost reduction in pharma manufacturing and scalable supply.